Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership1,679,013 shares
Ownership 2.80%
Millennium Management Llc ownership in VM4 / Vanda Pharmaceuticals Inc.

2026-01-09 - Millennium Management Llc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,679,013 shares of Vanda Pharmaceuticals Inc. (DE:VM4). This represents 2.8 percent ownership of the company. In their previous filing dated 2025-07-01 , Millennium Management Llc had reported owning 3,120,339 shares, indicating a decrease of -46.19 percent.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (VM4) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-01-09 2026-01-09 13G/A 3,120,339 1,679,013 -46.19 2.80 -47.17
2025-07-01 2025-07-01 13G 3,120,339 5.30

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:VM4 / Vanda Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,881,001 201,988 12.03 12,998 -12.23 0.0054
2026-02-17 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,679,013 -1,571,823 -48.35 14,809 -8.71 0.0062
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 3,250,836 130,497 4.18 16,222 10.14 0.0069
2025-08-14 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 3,120,339 980,748 45.84 14,728 49.98 0.0071
2025-05-15 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 2,139,591 1,470,898 219.97 9,821 206.59 0.0052
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 668,693 269,183 67.38 3,203 71.01 0.0016
2024-11-14 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 399,510 383,273 2,360.49 1,874 1,958.24 0.0009
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 16,237 -416,565 -96.25 92 -94.88 0.0000
2024-05-15 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 432,802 -565,490 -56.65 1,779 -57.79 0.0008
2024-02-14 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 998,292 -1,017,023 -50.46 4,213 -51.62 0.0018
2023-11-14 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 2,015,315 1,435,541 247.60 8,706 127.91 0.0044
2023-08-14 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 579,774 -1,181,954 -67.09 3,821 -68.07 0.0019
2023-05-15 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,761,728 -22,017 -1.23 11,962 -9.26 0.0069
2023-02-14 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,783,745 1,633,788 1,089.50 13,182 789.47 0.0073
2022-11-14 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 149,957 -1,040,453 -87.40 1,482 -88.58 0.0009
2022-08-15 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,190,410 356,418 42.74 12,975 37.56 0.0080
2022-05-16 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 833,992 394,318 89.68 9,432 36.74 0.0050
2022-02-14 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 439,674 -167,070 -27.54 6,898 -33.67 0.0035
2021-11-15 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 606,744 351,137 137.37 10,400 89.16 0.0062
2021-08-16 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 255,607 -461,108 -64.34 5,498 -48.93 0.0034
2021-05-17 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 716,715 73,005 11.34 10,765 27.28 0.0077
2021-02-16 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 643,710 476,053 283.94 8,458 422.10 0.0061
2020-11-16 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 167,657 167,657 1,620 0.0020
2020-08-14 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -280,178 -100.00 0 -100.00
2020-05-14 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 280,178 266,565 1,958.16 2,903 1,201.79 0.0065
2020-02-14 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 13,613 -448,362 -97.05 223 -96.37 0.0003
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 461,975 -60,350 -11.55 6,135 -16.64 0.0097
2019-08-15 2019-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 522,325 -135,697 -20.62 7,360 -39.21 0.0111
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 522,325 -135,697 7,360
2019-05-14 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 658,022 72,158 12.32 12,108 -20.91 0.0181
2019-02-15 2018-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 585,864 293,273 100.23 15,309 127.98 0.0239
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 585,864 15,309
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 292,591 -97,811 -25.05 6,715 -9.71 0.0082
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 390,402 -605,873 -60.81 7,437 -55.70 0.0097
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 996,275 -131,290 -11.64 16,787 -2.05 0.0224
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,127,565 -313,196 -21.74 17,139 -33.54 0.0237
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,440,761 1,006,282 231.61 25,790 264.16 0.0393
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 434,479 -134,864 -23.69 7,082 -11.15 0.0126
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 569,343 -451,828 -44.25 7,971 -51.06 0.0146
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,021,171 -660,510 -39.28 16,288 -41.79 0.0341
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,681,681 1,244,770 284.90 27,983 472.37 0.0469
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 436,911 -1,731,825 -79.85 4,889 -73.04 0.0112
2016-05-16 2016-03-31 13F VANDA PHARMACEUTICALS COM 921659108 2,168,736 632,966 41.21 18,131 26.81 0.0453
2016-02-16 2015-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,535,770 -259,698 -14.46 14,298 -29.40 0.0301
2015-11-16 2015-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,795,468 711,709 65.67 20,253 47.26 0.0392
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,083,759 -515,403 -32.23 13,753 -7.52 0.0260
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,599,162 786,392 96.75 14,872 27.78 0.0277
2015-02-17 2014-12-31 13F VANDA PHARMACEUTICALS COM 921659108 812,770 193,191 31.18 11,639 80.98 0.0247
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS COM 921659108 619,579 359,372 138.11 6,431 52.76 0.0163
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS COM 921659108 260,207 60,207 30.10 4,210 29.54 0.0117
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COM 921659108 200,000 -678,530 -77.23 3,250 -70.19 0.0094
2014-02-14 2013-12-31 13F VANDA PHARMACEUTICALS COM 921659108 878,530 -451,090 -33.93 10,903 -25.11 0.0344
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,329,620 780,722 142.23 14,559 228.28 0.0469
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS COM 921659108 548,898 548,898 4,435 0.0136
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM Call 50,100 250 n/a n/a n/a
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-02-14 2013-12-31 13F VANDA PHARMACEUTICALS COM Call 135,900 -16.52 1,687 -5.38 n/a n/a n/a
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS COM Call 162,800 170.43 1,783 266.87 n/a n/a n/a
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS COM Call 60,200 486 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM Put 100,000 499 n/a n/a n/a
2019-05-14 2019-03-31 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-15 2018-12-31 13F/A VANDA PHARMACEUTICALS COM Put 73,900 195.60 1,931 236.41 n/a n/a n/a
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS COM Put 73,900 1,931 n/a n/a n/a
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM Put 25,000 -89.01 574 -76.95 n/a n/a n/a
2014-02-14 2013-12-31 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS COM Put 227,400 25.91 2,490 70.66 n/a n/a n/a
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS COM Put 180,600 1,459 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.